Karen Stevens Dagerman
Journal of the American Medical Association (JAMA) · 2005–2006
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts Karen Stevens Dagerman
- Lon S. Schneider (in Psychiatry and Mental health)
Papers from Karen Stevens Dagerman's perspective
Ordered by how strongly the researchers Karen Stevens Dagerman trusts endorse each paper. Same corpus, a different order for every researcher.
- Controlling the risk of spurious findings from meta‐regression (Statistics in Medicine)
- How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
- Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
- Mendelian randomization: prospects, potentials, and limitations. (International Journal of Epidemiology)
- Random-effects model for meta-analysis of clinical trials: an update. (Contemporary Clinical Trials)
- Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease (Epidemiology)
- Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. (The Lancet)
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (PLoS ONE)
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. (American Journal of Epidemiology)
- Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant